Tech Company Financing Transactions

Codiak BioSciences Funding Round

Codiak BioSciences, operating out of Cambridge, raised $61 million from Arch Venture Partners, Flagship Pioneering and Alaska Permanent Fund.

Transaction Overview

Company Name
Codiak BioSciences
Announced On
1/26/2016
Transaction Type
Venture Equity
Amount
$61,000,000
Round
Series B
Investors

Arch Venture Partners (Lead Investor) (Steven Gillis)

Flagship Pioneering (Lead Investor) (Noubar Afeyan)

Alaska Permanent Fund

Alexandria Venture Investments

Fidelity Management & Research Company

Proceeds Purpose
With these additional resources we will continue to build our world-class team to realize the broad transformative potential of exosomes for multiple therapeutic and diagnostic uses. Codiak intends to use the proceeds of this round primarily to advance research and clinical development of exosomes for therapeutic and diagnostic purposes.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
500 Technology Sq. 9th Floor
Cambridge, MA 02139
USA
Phone
(617) 949-4100
Website
www.codiakbio.com
Email Address
[email protected]
Overview
Codiak Biosciences (Nasdaq: CDAK) is developing multiple platforms for both therapeutic and diagnostic applications based on a growing appreciation for exosome biology.
Profile
Codiak BioSciences LinkedIn Company Profile
Social Media
Codiak BioSciences Company Twitter Account
Company News
Codiak BioSciences News
Facebook
Codiak BioSciences on Facebook
YouTube
Codiak BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Douglas Williams
  Douglas Williams LinkedIn Profile  Douglas Williams Twitter Account  Douglas Williams News  Douglas Williams on Facebook
Chief Financial Officer
Linda Bain
  Linda Bain LinkedIn Profile  Linda Bain Twitter Account  Linda Bain News  Linda Bain on Facebook
Vice President
Sriram Sathy
  Sriram Sathy LinkedIn Profile  Sriram Sathy Twitter Account  Sriram Sathy News  Sriram Sathy on Facebook
Vice President
Benny Sorensen
  Benny Sorensen LinkedIn Profile  Benny Sorensen Twitter Account  Benny Sorensen News  Benny Sorensen on Facebook
VP - Manufacturing
Konstantin Konstantinov
  Konstantin Konstantinov LinkedIn Profile  Konstantin Konstantinov Twitter Account  Konstantin Konstantinov News  Konstantin Konstantinov on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/26/2016: ConsortiEX venture capital transaction
Next: 1/26/2016: XG Sciences venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.